Industry & Policy News

[University of Toronto] The University of Toronto (U of T) is collaborating with the University Health Network, the Hospital for Sick Children, and Sunnybrook Research Institute on a new program that aims to leverage the expertise of entrepreneurs and business leaders to advance commercialization of emerging medical technologies and regenerative medicine research.

[Business Insider] Healthcare innovator Dr. David Greene announced the establishment of the esteemed Dr. David Greene Scholarship for Medical Students, aimed at fostering excellence and innovation in the medical community. This scholarship, valued at $1,000, presents a unique chance for undergraduate students to further their medical ambitions.

[Hubrecht Institute] Delilah Hendriks, researcher from the Organoid group, Oncode researcher, and affiliated group leader at the Princess Máxima Center has received a Young Investigator Grant from the Dutch Cancer Society.

[Parent Project Muscular Dystrophy] Parent Project Muscular Dystrophy (PPMD) and Duchenne UK announced the recipient of their Joint Call for Therapeutic Projects. Professor Peter Kang MD, from the University of Minnesota Medical School, has been awarded the grant for his research project titled “Phase I clinical trial of myogenic progenitors for DMD.”

[Aspen Neuroscience] Aspen Neuroscience, Inc. announced that the first patient has been dosed in the ASPIRO trial, a Phase I/IIa open label clinical trial to assess safety and tolerability of ANPD001.

[UC Davis Health] Researchers in the UC Davis College of Biological Sciences have received a grant to study the role of the cerebellum in autism.